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Letter to Editor 
Drug Induced Acute Pancreatitis 
Sir, 
cute pancreatitis is an inflammatory process of 
pancreas with varying involvement of other 
regional tissues or remote organs system [1]. It is 
characterized by abdominal pain, nausea, elevated 
pancreatic enzymes (serum lipase, serum amylase) greater 
than three times the upper limit of normal [1, 2]. Some 
drugs are responsible for causing pancreatitis and about 
2% of acute pancreatic cases are due to drugs.  
A 16 years old male patient was admitted in our 
hospital with complaints of abdominal pain and vomiting 
for one day. He had past history of generalized tonic clonic 
seizures and he was on medication Valproic acid, 
Oxcarbazepine and Clobazam. He has no history of 
gallstones, alcohol abuse, and endoscopic retrograde 
cholangeopancreatography procedure, and trauma, surgical 
procedures near pancreas, hyperlipidemia, infections and 
hypercalcemia. On physical examination, abdomen 
showed epigastric tenderness, crepations in the lungs and 
other physical findings were normal.  
Laboratory investigations showed elevated serum 
lipase (1685 U/L), serum amylase (45 U/L), ESR (70 
mm/1hour), and total bilirubin (0.6mg/dl). His SGOT, 
SGPT, triglyceride, total cholesterol, total HDL, total 
VLDL, total LDL, and calcium levels were in normal 
range. Urine culture revealed no growth. Chest X-ray 
revealed right basal pneumonitis with effusion. Computed 
tomography abdomen revealed features consistent with 
acute pancreatitis. Upon excluding all other etiological 
factors case was suspected as drug induced acute 
pancreatitis. Drugs which were previously used were 
stopped and anticonvulsants like Phenytoin and 
Levitiracetam were added to control seizures. Patient 
condition was improved after 10days with clinical 
symptoms. 
80% of the acute pancreatic cases occur due to 
gallstones and alcohol abuse [1,3], while 2% of the cases 
may be due to drugs [4-6]. Different classifications are 
used to describe casual relationship of specific agents to 
cause acute pancreatitis [4]: 1) Class1 drugs – Drugs have 
20 or more reported cases at least 1 report of positive 
rechallange. 2) Class 2 drugs - Drugs have more than 10 
but less than 20 reported cases, with or without positive 
rechallange. 3) Class 3 drugs - Drugs that have been 
implicated in pancreatitis, including those with 10 or few 
reported cases or unpublished reports of pancreatitis. 
Different mechanisms are involved to cause drug 
induced pancreatitis like hypersensitivity (onset after 4-8 
weeks of use), accumulation of toxic metabolite (onset 
after several months of use), and hypertriglyceredemia 
(onset after several months of use) and intrinsic toxicity 
which sometimes related to overdose (onset may be almost 
immediate) [1]. Spasm of oddi is another mechanism. 
According to above mechanism class 1 drugs include 
Azathiprine, Corticosteroids, Didanosine, Cytarabine, 
Estrogens,Exenatide, Furosemide, Glyburide, 
Mercaptopurine, Mesalamine, Opiods, Pentamidine, 
Sitagliptin, Sulphamethoxazole and Thioprim, 
Sulphasalazine, Sulindac, Tetracyclines and Valproic acid 
[4]. Class 2 drugs include Carbamazepine, Cisplatin, 
Enalapril,Erythromycin, Hydrochlorthiazide, Interferon 
alfa, Isoniazid, Lamivudine, Metformin, Octreotide, 
Rifampin, Paracetamol [4].  
Based on the patient’s medication history of valproic 
acid use, signs and symptoms, and investigation findings, 
we made a diagnosis of drug induced acute pancreatitis 
due to Valproic acid. It comes under class 1 drug which 
causes pancreatitis after several months of use by causing 
accumulation of its toxic metabolites. So, we replaced the 
culprit drug with anticonvulsant drug. Here, we reported 
this case to make health care professionals aware about the 
drug induced problems. 
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